Smartphone-based rehabilitation after ICU discharge

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective multicenter cohort enrolls adults (≥19 years) discharged from the ICU after more than 48 hours at two tertiary hospitals in Seoul, South Korea. Participants receive individualized daily rehabilitation sessions (up to 30 minutes) delivered through the Tuntun Rehabilitation Assistant smartphone platform, with a researcher assisting during the first five sessions. Physical and cognitive function, mobility, quality of life, platform usage, and safety events are measured at baseline, two weeks, hospital discharge, and during follow-up. Approximately 70 participants will be recruited to determine feasibility, usability, and preliminary clinical signals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 19 years or older.
* Admission to the intensive care unit (ICU) for more than 48 hours.
* Hospitalization at Asan Medical Center or Seoul National University Bundang Hospital.
* Discharge from the ICU at the time of enrollment.
* Ownership of a smartphone and ability to operate a digital rehabilitation platform.
* Ability to understand the study procedures and provide voluntary written informed consent.

Exclusion Criteria:

* Medical conditions that contraindicate participation in rehabilitation exercise, as determined by the attending physician.
* Severe cognitive impairment or communication difficulties that interfere with understanding or following study instructions.
* Unstable medical conditions requiring ongoing intensive medical treatment.
* Inability to use a smartphone or digital platform independently.
* Refusal to participate or withdrawal of informed consent.

Where it's running

• Asan Medical Center
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: Won Kim, Associate professor
• Email: duocl79@gmail.com
• Phone: 82+02-3010-1694

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy

  This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.

  Recruiting Phase 2 Asan Medical Center · Seoul · NCT07926217

• Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk

  This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.

  Recruiting Asan Medical Center · Seoul · NCT07857291

• AI-based prediction of five major diseases using integrated health data

  Researchers are testing an AI model to see if they can predict the onset of five major diseases in adults 30–65 by combining medical records with biospecimens and lifestyle data.

  Recruiting Asan Medical Center · Seoul, Seoul Special City · NCT07595718

• Noninferiority test of a sirolimus-ascorbic acid stent vs everolimus stent in heart disease patients

  This study tests whether a sirolimus-ascorbic acid eluting stent works as well as the standard everolimus-eluting stent for people with coronary artery disease undergoing PCI.

  Recruiting Asan Medical Center · Seoul · NCT07566091

• Blood Viscosity and Outcomes After Elective Brain Surgery

  This study will test whether measures of blood viscosity taken during elective intracranial surgery relate to how patients recover and if they have postoperative complications.

  Recruiting Asan Medical Center · Seoul, Songpa · NCT07530393

• Flu vaccine strategies for adults with blood cancers

  This study will test three different flu vaccines to see which gives the strongest antibody and T-cell responses in adults with blood cancers, including people after autologous stem cell transplant or CAR-T therapy.

  Recruiting Phase 3 Asan Medical Center · Seoul · NCT07485855

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.